Innovactive Pharmaceticals Llp
Founded in 2021 and headquartered in Telangana, India.
2021 | Hyderabad, Telangana (India) | Active
Innovactive Pharmaceticals Llp Profile
Key Indicators
- Obligation of Contribution ₹ 0.10 M
- Company Age 4 Year, 22 Days
- Last Filing with ROC 31 Mar 2022
About Innovactive Pharmaceticals Llp
Innovactive Pharmaceticals Llp (IPL) is 4 Year, 22 Days old Limited Liability Partnership 03 February 2021. Its registered office is in Hyderabad, Telangana, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2022 (FY 2021-2022). It's Total Obligation of Contribution is Rs 0.10 M as per MCA.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN/FCRN
AAV-7041
- Incorporation Date
03 Feb 2021
- Date of Accounts and Solvency Statement
31 Mar 2022
- ROC Code
Roc-Hyderabad
- Company Classification
Limited Liability Partnership
Industry
Chemicals
Who are the key members and board of directors at Innovactive Pharmaceticals Llp?
Designated Partners (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sreenivas Parupati  | Designated Partner | 03-Feb-2021 | Current |
| Suprith Parupati | Designated Partner | 03-Feb-2021 | Current |
Financial Performance of Innovactive Pharmaceticals Llp.
Enhance accessibility to Innovactive Pharmaceticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Innovactive Pharmaceticals Llp?
Unlock access to Innovactive Pharmaceticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Rajapushpa Estates LlpSreenivas Parupati is a mutual person
- Rajapushpa Realty Llp
Sreenivas Parupati is a mutual person
- Rajapushpa Asset Management Llp
Sreenivas Parupati is a mutual person
- Rajapushpa Prime Llp
Sreenivas Parupati is a mutual person
- Rajapushpa Cements Limited
Sreenivas Parupati is a mutual person
- Rajapushpa Infra Private Limited
Sreenivas Parupati is a mutual person
Charges (Loans)
There are no Open Charges registered against the LLP as per our records.
How Many Employees Work at Innovactive Pharmaceticals Llp?
Unlock and access historical data on people associated with Innovactive Pharmaceticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Innovactive Pharmaceticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innovactive Pharmaceticals Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.